Security Snapshot

KIORA PHARMACEUTICALS INC - Common Shares (KPRX) Institutional Ownership

CUSIP: 49721T101

13F Institutional Holders and Ownership History from Q4 2021 to Q3 2022

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / Common Shares
Symbol
KPRX on Nasdaq
Shares outstanding
4,693,697
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • KPRX - KIORA PHARMACEUTICALS INC - Common Shares is tracked under CUSIP 49721T101.
  • Latest finished 13F holder period is not available.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 10 to 0 between Q2 2022 and Q3 2022.
  • Reported value moved from $391,000 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Security key

49721T101

Latest holder period

n/a

13F holders

13D/G owners

1

CIK / CUSIP context first

KPRX full holder history KIORA PHARMACEUTICALS INC SEC filings KIORA PHARMACEUTICALS INC company facts KIORA PHARMACEUTICALS INC insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Significant Owners of KIORA PHARMACEUTICALS INC - Common Shares (KPRX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Rosalind Advisors, Inc. 9.9% 0% 464,676 0% Rosalind Advisors, Inc. 31 Dec 2025

Institutional Holders of KIORA PHARMACEUTICALS INC - Common Shares (KPRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q3 0 $0 -$391,000 0
2022 Q2 833,645 $391,000 -$6,203 $0.47 10
2022 Q1 830,388 $517,000 -$35,415 $0.62 12
2021 Q4 803,445 $1,213,000 +$1,213,000 $1.51 8
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .